Serina Therapeutics, Inc. (SER) Free cash flow 2017–2025
Serina Therapeutics, Inc. (SER) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.0MFY2025 · since FY2017: -$6.3M → -$18.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.0M | -5.0% |
| FY2024 | -$17.2M | -475.8% |
| FY2023 | -$3.0M | — |
| FY2020 | -$7.8M | +27.4% |
| FY2019 | -$10.8M | -34.7% |
| FY2018 | -$8.0M | -27.5% |
| FY2017 | -$6.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice